Scott A. Waldman

18.0k total citations · 6 hit papers
346 papers, 13.4k citations indexed

About

Scott A. Waldman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Scott A. Waldman has authored 346 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 87 papers in Oncology and 49 papers in Immunology. Recurrent topics in Scott A. Waldman's work include Colorectal Cancer Treatments and Studies (32 papers), Escherichia coli research studies (31 papers) and Cancer Research and Treatments (30 papers). Scott A. Waldman is often cited by papers focused on Colorectal Cancer Treatments and Studies (32 papers), Escherichia coli research studies (31 papers) and Cancer Research and Treatments (30 papers). Scott A. Waldman collaborates with scholars based in United States, Belgium and Canada. Scott A. Waldman's co-authors include Ferid Murad, Robert M. Rapoport, Stephanie Schulz, Giovanni M. Pitari, Adam E. Snook, André Terzic, Jason Y. Park, Jieru E. Lin, Terry Hyslop and Shiva Kazerounian and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Scott A. Waldman

339 papers receiving 13.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guanylyl Cyclases and Signaling by Cyclic GMP

2000 975 citations Giovanni M. Pitari, Stephanie Schulz et al. profile →
Cyclic GMP synthesis and function.

1987 758 citations Scott A. Waldman et al. profile →
Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.

1984 608 citations Scott A. Waldman et al. profile →
Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.

1984 424 citations Scott A. Waldman et al. Proceedings of the National Academy of Sciences profile →
Cardiopoietic Stem Cell Therapy in Heart Failure

2013 348 citations Scott A. Waldman, André Terzic et al. profile →
Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung.

1986 298 citations Scott A. Waldman et al. profile →

Peers

Countries citing papers authored by Scott A. Waldman

Since Specialization

Citations

This map shows the geographic impact of Scott A. Waldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Waldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Waldman more than expected).

Fields of papers citing papers by Scott A. Waldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Waldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Waldman. The network helps show where Scott A. Waldman may publish in the future.

Co-authorship network of co-authors of Scott A. Waldman

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Waldman. A scholar is included among the top collaborators of Scott A. Waldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Waldman. Scott A. Waldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomarkers for Managing Neurodegenerative Diseases 2024 ·Biomolecules ·(unknown), Adam E. Snook, Scott A. Waldman	12
2	CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy 2024 ·Cancer Biology & Therapy ·Trevor R. Baybutt, (unknown), (unknown), (unknown), Robert D. Carlson, Scott A. Waldman, Adam E. Snook	2
3	Gamma Secretase Inhibition Sensitizes Pancreatic Adenocarcinoma Tumors to RT In Vivo 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Ryan T. Hughes, Varsha Gandhi, Adam E. Snook, Scott A. Waldman, Adam C. Mueller	1
4	Fundamental Neurochemistry Review: The role of enteroendocrine cells in visceral pain 2023 ·Journal of Neurochemistry ·(unknown), Tyler D. Alexander, Manuel Covarrubias, Scott A. Waldman	3
5	Intestinal neuropod cell GUCY2C regulates visceral pain 2022 ·Journal of Clinical Investigation ·(unknown), (unknown), Tyler D. Alexander, (unknown), (unknown), Lan Cheng, Angelo C. Lepore, Adam E. Snook, Manuel Covarrubias, Scott A. Waldman	13
6	Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer 2022 ·Personalized Medicine ·(unknown), (unknown), Madison Crutcher, Adam E. Snook, Scott A. Waldman	5
7	Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy 2022 ·npj Vaccines ·John C. Flickinger, (unknown), Jagmohan Singh, Robert D. Carlson, (unknown), Trevor R. Baybutt, Jeffrey A. Rappaport, (unknown), (unknown), Scott A. Waldman, Adam E. Snook	11
8	Guanylyl Cyclase C As A Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies 2021 ·Biomarkers in Medicine ·John C. Flickinger, Jeffrey A. Rappaport, (unknown), Trevor R. Baybutt, (unknown), Adam E. Snook, Scott A. Waldman	1
9	Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers 2021 ·Cancer Biology & Therapy ·David S. Weinberg, Nathan R. Foster, (unknown), (unknown), Walter K. Kraft, (unknown), David Kastenberg, (unknown), (unknown), (unknown), Paul J. Limburg, Scott A. Waldman	7
10	Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases 2018 ·Cancer Immunology Research ·Michael S. Magee, Tara S. Abraham, Trevor R. Baybutt, John C. Flickinger, (unknown), Glen P. Marszalowicz, Priyanka Prajapati, Adam R. Hersperger, Scott A. Waldman, Adam E. Snook	115
11	Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders 2018 ·Gut ·Scott A. Waldman, Michael Camilleri	68
12	Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention 2017 ·Cancer Prevention Research ·David S. Weinberg, Jieru E. Lin, Nathan R. Foster, (unknown), Asad Umar, Drew K. Seisler, Walter K. Kraft, David Kastenberg, (unknown), Paul J. Limburg, Scott A. Waldman	33
13	GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome 2017 ·Cancer Research ·Peng Li, Evan Wuthrick, Jeffrey A. Rappaport, (unknown), Jieru E. Lin, Glen P. Marszalowicz, Adam E. Snook, Tingting Zhan, Terry Hyslop, Scott A. Waldman	12
14	Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis 2016 ·Cancer Research ·Jieru E. Lin, Francheska Colón‐González, Erik Blomain, Gilbert W. Kim, (unknown), (unknown), (unknown), Adam E. Snook, Tingting Zhan, Terry Hyslop, Michal Tomczak, Richard S. Blumberg, Scott A. Waldman	47
15	GUCY2C ligand replacement to prevent colorectal cancer 2016 ·Cancer Biology & Therapy ·Erik Blomain, (unknown), Scott A. Waldman	15
16	The Paracrine Hormone for the GUCY2C Tumor Suppressor, Guanylin, Is Universally Lost in Colorectal Cancer 2014 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Jieru E. Lin, Peng Li, Adam E. Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A. Girondo, Hallgeir Rui, Terry Hyslop, Scott A. Waldman	49
17	Intestinal GUCY2C Prevents TGF-β Secretion Coordinating Desmoplasia and Hyperproliferation in Colorectal Cancer 2013 ·Cancer Research ·(unknown), Jieru E. Lin, Gilbert W. Kim, Glen P. Marszalowicz, Peng Li, (unknown), Erik Blomain, Satish Rattan, Adam E. Snook, Stephanie Schulz, Scott A. Waldman	20
18	Occult Tumor Burden Predicts Disease Recurrence in Lymph Node–Negative Colorectal Cancer 2011 ·Clinical Cancer Research ·Terry Hyslop, David S. Weinberg, Stephanie Schulz, Alan Barkun, Scott A. Waldman	22
19	Aprepitant for the prevention of nausea and vomiting associated with chemotherapy and postoperative recovery 2008 ·Expert Review of Clinical Pharmacology ·(unknown), Scott A. Waldman, Walter K. Kraft	4
20	Bacterial enterotoxins are associated with resistance to colon cancer 2003 ·Proceedings of the National Academy of Sciences ·Giovanni M. Pitari, Leonid V. Zingman, Denice M. Hodgson, А. Э. Алексеев, Shideh Kazerounian, Martin Bienengraeber, György Hajnóczky, André Terzic, Scott A. Waldman	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact